Your browser doesn't support javascript.
loading
Network impact score is an independent predictor of post-stroke cognitive impairment: A multicenter cohort study in 2341 patients with acute ischemic stroke.
Biesbroek, J Matthijs; Weaver, Nick A; Aben, Hugo P; Kuijf, Hugo J; Abrigo, Jill; Bae, Hee-Joon; Barbay, Mélanie; Best, Jonathan G; Bordet, Régis; Chappell, Francesca M; Chen, Christopher P L H; Dondaine, Thibaut; van der Giessen, Ruben S; Godefroy, Olivier; Gyanwali, Bibek; Hamilton, Olivia K L; Hilal, Saima; Huenges Wajer, Irene M C; Kang, Yeonwook; Kappelle, L Jaap; Kim, Beom Joon; Köhler, Sebastian; de Kort, Paul L M; Koudstaal, Peter J; Kuchcinski, Gregory; Lam, Bonnie Y K; Lee, Byung-Chul; Lee, Keon-Joo; Lim, Jae-Sung; Lopes, Renaud; Makin, Stephen D J; Mendyk, Anne-Marie; Mok, Vincent C T; Oh, Mi Sun; van Oostenbrugge, Robert J; Roussel, Martine; Shi, Lin; Staals, Julie; Valdés-Hernández, Maria Del C; Venketasubramanian, Narayanaswamy; Verhey, Frans R J; Wardlaw, Joanna M; Werring, David J; Xin, Xu; Yu, Kyung-Ho; van Zandvoort, Martine J E; Zhao, Lei; Biessels, Geert Jan.
Afiliação
  • Biesbroek JM; Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht, the Netherlands. Electronic address: j.m.biesbroek@umcutrecht.nl.
  • Weaver NA; Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht, the Netherlands.
  • Aben HP; Department of Neurology, Elisabeth Tweesteden Hospital, Tilburg, the Netherlands.
  • Kuijf HJ; Image Sciences Institute, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Abrigo J; Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Bae HJ; Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.
  • Barbay M; Department of Neurology, Amiens University Hospital, Laboratory of Functional Neurosciences (UR UPJV 4559), Jules Verne Picardy University, 80054 Amiens Cedex, France.
  • Best JG; Stroke Research Centre, Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, Russell Square House, 10 - 12 Russell Square, London WC1B 5EH, UK.
  • Bordet R; Université Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France.
  • Chappell FM; Neuroimaging Sciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK; UK Dementia Research Institute at the University of Edinburgh, Edinburgh, UK.
  • Chen CPLH; Department of Pharmacology, National University of Singapore, Singapore, Singapore; Memory, Aging and Cognition Center, National University Health System, Singapore, Singapore.
  • Dondaine T; Université Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France.
  • van der Giessen RS; Department of Neurology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Godefroy O; Department of Neurology, Amiens University Hospital, Laboratory of Functional Neurosciences (UR UPJV 4559), Jules Verne Picardy University, 80054 Amiens Cedex, France.
  • Gyanwali B; Department of Pharmacology, National University of Singapore, Singapore, Singapore; Memory, Aging and Cognition Center, National University Health System, Singapore, Singapore.
  • Hamilton OKL; Neuroimaging Sciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK; UK Dementia Research Institute at the University of Edinburgh, Edinburgh, UK.
  • Hilal S; Department of Pharmacology, National University of Singapore, Singapore, Singapore; Memory, Aging and Cognition Center, National University Health System, Singapore, Singapore; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, S
  • Huenges Wajer IMC; Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht, the Netherlands; Experimental Psychology, Helmholtz Institute, Utrecht University, the Netherlands.
  • Kang Y; Department of Psychology, Hallym University, Chuncheon, South Korea.
  • Kappelle LJ; Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht, the Netherlands.
  • Kim BJ; Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.
  • Köhler S; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.
  • de Kort PLM; Department of Neurology, Elisabeth Tweesteden Hospital, Tilburg, the Netherlands.
  • Koudstaal PJ; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore.
  • Kuchcinski G; Université Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France.
  • Lam BYK; Division of Neurology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; Therese Pei Fong Chow Research Centre for Prevention of Dementia, Margaret Kam Ling Cheung Research Centre for Management of Parkinsonism, Gerald Choa Neuroscience Centre, The C
  • Lee BC; Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Lee KJ; Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.
  • Lim JS; Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Lopes R; Université Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France.
  • Makin SDJ; Centre for Rural Health, University of Aberdeen, Aberdeen, UK.
  • Mendyk AM; Université Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France.
  • Mok VCT; Division of Neurology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; Therese Pei Fong Chow Research Centre for Prevention of Dementia, Margaret Kam Ling Cheung Research Centre for Management of Parkinsonism, Gerald Choa Neuroscience Centre, The C
  • Oh MS; Department of Neurology, Hallym University Sacred Hospital, Hallym Neurological Institute, Hallym University College of Medicine, Anyang, South Korea.
  • van Oostenbrugge RJ; Department of Neurology, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Roussel M; Department of Neurology, Amiens University Hospital, Laboratory of Functional Neurosciences (UR UPJV 4559), Jules Verne Picardy University, 80054 Amiens Cedex, France.
  • Shi L; Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong SAR, China; BrainNow Research Institute, Shenzhen, Guangdong Province, China.
  • Staals J; Department of Neurology, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Valdés-Hernández MDC; Neuroimaging Sciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK; UK Dementia Research Institute at the University of Edinburgh, Edinburgh, UK.
  • Venketasubramanian N; Raffles Neuroscience Centre, Raffles Hospital, Singapore, Singapore.
  • Verhey FRJ; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.
  • Wardlaw JM; Neuroimaging Sciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK; UK Dementia Research Institute at the University of Edinburgh, Edinburgh, UK.
  • Werring DJ; Stroke Research Centre, Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, Russell Square House, 10 - 12 Russell Square, London WC1B 5EH, UK.
  • Xin X; Department of Pharmacology, National University of Singapore, Singapore, Singapore; Memory, Aging and Cognition Center, National University Health System, Singapore, Singapore.
  • Yu KH; Department of Neurology, Hallym University Sacred Hospital, Hallym Neurological Institute, Hallym University College of Medicine, Anyang, South Korea.
  • van Zandvoort MJE; Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht, the Netherlands; Experimental Psychology, Helmholtz Institute, Utrecht University, the Netherlands.
  • Zhao L; BrainNow Research Institute, Shenzhen, Guangdong Province, China.
  • Biessels GJ; Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht, the Netherlands.
Neuroimage Clin ; 34: 103018, 2022.
Article em En | MEDLINE | ID: mdl-35504223
ABSTRACT

BACKGROUND:

Post-stroke cognitive impairment (PSCI) is a common consequence of stroke. Accurate prediction of PSCI risk is challenging. The recently developed network impact score, which integrates information on infarct location and size with brain network topology, may improve PSCI risk prediction.

AIMS:

To determine if the network impact score is an independent predictor of PSCI, and of cognitive recovery or decline.

METHODS:

We pooled data from patients with acute ischemic stroke from 12 cohorts through the Meta VCI Map consortium. PSCI was defined as impairment in ≥ 1 cognitive domain on neuropsychological examination, or abnormal Montreal Cognitive Assessment. Cognitive recovery was defined as conversion from PSCI < 3 months post-stroke to no PSCI at follow-up, and cognitive decline as conversion from no PSCI to PSCI. The network impact score was related to serial measures of PSCI using Generalized Estimating Equations (GEE) models, and to PSCI stratified according to post-stroke interval (<3, 3-12, 12-24, >24 months) and cognitive recovery or decline using logistic regression. Models were adjusted for age, sex, education, prior stroke, infarct volume, and study site.

RESULTS:

We included 2341 patients with 4657 cognitive assessments. PSCI was present in 398/844 patients (47%) <3 months, 709/1640 (43%) at 3-12 months, 243/853 (28%) at 12-24 months, and 208/522 (40%) >24 months. Cognitive recovery occurred in 64/181 (35%) patients and cognitive decline in 26/287 (9%). The network impact score predicted PSCI in the univariable (OR 1.50, 95%CI 1.34-1.68) and multivariable (OR 1.27, 95%CI 1.10-1.46) GEE model, with similar ORs in the logistic regression models for specified post-stroke intervals. The network impact score was not associated with cognitive recovery or decline.

CONCLUSIONS:

The network impact score is an independent predictor of PSCI. As such, the network impact score may contribute to a more precise and individualized cognitive prognostication in patients with ischemic stroke. Future studies should address if multimodal prediction models, combining the network impact score with demographics, clinical characteristics and other advanced brain imaging biomarkers, will provide accurate individualized prediction of PSCI. A tool for calculating the network impact score is freely available at https//metavcimap.org/features/software-tools/lsm-viewer/.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acidente Vascular Cerebral / Disfunção Cognitiva / AVC Isquêmico Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Neuroimage Clin Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acidente Vascular Cerebral / Disfunção Cognitiva / AVC Isquêmico Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Neuroimage Clin Ano de publicação: 2022 Tipo de documento: Article